Author

Mauro Martins Teixeira

Professor, Department Bioquimica e Imunologia, UFMG - Cited by 48,729 - inflammation - leukocyte recruitment - infection - anti-inflammatory drugs - clinical trials

Biography

Mauro Martins Teixeira is currently working as a Professor in the Department of Medicine. Mauro Martins Teixeira is serving as an editorial member and reviewer of several international reputed journals. Mauro Martins Teixeira has successfully completed his Administrative responsibilities His research interests includes Medicine. Mauro Martins Teixeira  has authored of many research articles/books related to Medicine.
Title
Cited by
Year
Association between genetic variants in TREM1, CXCL10, IL4, CXCL8 and TLR7 genes with the occurrence of congenital Zika syndrome and severe microcephaly
Association between genetic variants in TREM1, CXCL10, IL, CXCL8 and TLR7 genes with the occurrence of congenital Zika syndrome and severe microcephalyCNO Santos, LS Magalhães, ABL Fonseca, AJB Bispo, RLS Porto, ...Scientific Reports 13 (1), 366, 2023202
4
2023
Therapeutic treatment with phosphodiesterase-4 inhibitors alleviates kidney injury and renal fibrosis by increasing MMP-9 in a doxorubicin-induced nephrotoxicity mouse model
WC Costa, VA Beltrami, GH Campolina-Silva, CM Queiroz-Junior, ...International Immunopharmacology 115, 109583, 030
2
2023
Preclinical development of kinetin as a safe error-prone SARS-CoV-2 antiviral able to attenuate virus-induced inflammation
Preclinical development of kinetin as a safe error-prone SARS-CoV- antiviral able to attenuate virus-induced inflammationTML Souza, VD Pinho, CF Setim, CQ Sacramento, R Marcon, ...Nature Communications 14 (1), 199, 030
2
2023
Dysbiotic oral microbiota contributes to alveolar bone loss associated with obesity in mice
IM Chaves, MC Zicker, AO Laranjeira, ALM Silveira, DC Aguiar, ...Journal of Applied Oral Science 30, 0
2
2022
PI3K Isoforms in Cell Signalling and Innate Immune Cell Responses
I Galvão, LP Sousa, MM Teixeira, V PinhoPi3k and Akt Isoforms in Immunity: Mechanisms and Therapeutic Opportunities …, 0
2
2022
1
2023
Considering and reporting sex as an experimental variable II: An update on progress in the British Journal of Pharmacology
SC Stanford, S Alexander, G Cirino, CH George, PA Insel, D Kendall, Y Ji, ...British journal of pharmacology, 2023202
1
2023
Plasmin and plasminogen prevent sepsis severity by reducing neutrophil extracellular traps and systemic inflammation
JP Vago, I Zaidan, LO Perucci, LF Brito, LCR Teixeira, CMS Silva, ...JCI insight 8 (8), 2023202
1
2023
TNF/iNOS/NO pathway mediates host susceptibility to endothelial-dependent circulatory failure and death induced by betacoronavirus infection
I Vieira-Alves, ARP Alves, NMV Souza, TL Melo, LMC Coimbra Campos, ...Clinical Science 37 (7), 543-559, 2023202
1
2023
Tumour necrosis factor plays a deleterious role in the pathogenesis of chikungunya virus infection
TP Moreira, CDF Sousa, VR Melo Costa, CM Queiroz‐Junior, FM Santos, ...Immunology 68 (3), 444-458, 2023202
1
2023
Guidance for the use and reporting of anaesthetic agents in BJP manuscripts involving work with animals
J Ingrande, HH Patel, D Kendall, B Stefanska, S Alexander, M Bakhle, ...British Journal of Pharmacology 80 (3), 255-263, 2023202
1
2023
Current Drug Targets (CDT) special issue on Covid-19 and Coagulopathy Fibrinolysis in COVID-19: impact on clot lysis and modulation of inflammation.
Current Drug Targets (CDT) special issue on Covid-9 and Coagulopathy Fibrinolysis in COVID-9: impact on clot lysis and modulation of inflammation.MA Sugimoto, LO Perucci, LP Tavares, MM Teixeira, LP SousaCurrent Drug Targets, 2022202
1
2022